Sign inJoin waitlistJoin the waitlist

FS

Fernando Santini

Assistant Attending Physician · New York Presbyterian Hospital

Credentials: · ·

History

Memorial Sloan Kettering Westchester
2021–Present

Research

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC
Cancer Immunology Research · 2018 · First of 14 authors · 287 citations
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC
New England Journal of Medicine · 2023 · 208 citations
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
Review · Lung Cancer · 2019 · Last of 3 authors · 178 citations

AD
Alexander Drilon
10 papers
Charles Rudin
4 papers
GH
Guilherme Harada
4 papers · 1 as a fellow
JE
Juliana Eng
4 papers
MK
Mark Kris
4 papers
BL
Bob Li
3 papers
IP
Isabel Preeshagul
3 papers
JC
Jamie Chaft
3 papers
Joshua Sabari
3 papers · 2 as a fellow
KA
Kathryn Arbour
3 papers · 2 as a fellow
MG
Michelle Ginsberg
3 papers
SY
Soo-Ryum Yang
3 papers

Clinical trials

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Site PI · Recruiting · Phase 1
Nuvalent Inc.
2024–2027